We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-2.62%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.84B
AUM Growth
-$154M
Cap. Flow
+$25M
Cap. Flow %
0.52%
Top 10 Hldgs %
18.29%
Holding
1,493
New
82
Increased
580
Reduced
615
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 18.65%
2 Financials 10.44%
3 Healthcare 9.35%
4 Industrials 8.91%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VONG icon
1076
Vanguard Russell 1000 Growth ETF
VONG
$45.4B
$356K 0.01%
5,207
+75
+1% +$5.33K
RH icon
1077
RH
RH
$3.47B
$356K 0.01%
1,345
IWY icon
1078
iShares Russell Top 200 Growth ETF
IWY
$16.5B
$355K 0.01%
2,309
DRIV icon
1079
Global X Autonomous & Electric Vehicles ETF
DRIV
$391M
$353K 0.01%
15,018
+449
+3% +$11.4K
SLP icon
1080
Simulations Plus
SLP
$371M
$352K 0.01%
8,439
-1,737
-17% -$78.8K
SLGN icon
1081
Silgan Holdings
SLGN
$4.36B
$352K 0.01%
8,160
KNF icon
1082
Knife River
KNF
$3.83B
$351K 0.01%
+7,192
New +$341K
OTEX icon
1083
Open Text
OTEX
$5.83B
$351K 0.01%
+10,000
New +$391K
RELY icon
1084
Remitly
RELY
$5.01B
$348K 0.01%
+13,809
New +$311K
HGLB
1085
Highland Global Allocation Fund
HGLB
$178M
$348K 0.01%
43,500
+1,000
+2% +$8.38K
VTRS icon
1086
Viatris
VTRS
$18.7B
$346K 0.01%
35,092
-500
-1% -$5.21K
PCN
1087
PIMCO Corporate & Income Strategy Fund
PCN
$889M
$346K 0.01%
28,399
+2,127
+8% +$28.9K
AEVA
1088
Aeva Technologies
AEVA
$1.7B
$346K 0.01%
90,345
+15,571
+21% +$82.3K
DOCS icon
1089
Doximity
DOCS
$4.68B
$344K 0.01%
16,221
+32
+0.2% +$873
SDHY
1090
PGIM Short Duration High Yield Opportunities Fund
SDHY
$403M
$344K 0.01%
23,742
+470
+2% +$7.08K
VRNT
1091
DELISTED
Verint Systems
VRNT
$344K 0.01%
14,949
-844
-5% -$27.2K
BAM icon
1092
Brookfield Asset Management
BAM
$88B
$340K 0.01%
10,210
-5,265
-34% -$178K
POWL icon
1093
Powell Industries
POWL
$7.6B
$340K 0.01%
12,300
-1,500
-11% -$37.2K
ECAT icon
1094
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.58B
$337K 0.01%
22,782
+758
+3% +$11.7K
MUJ icon
1095
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$652M
$334K 0.01%
32,975
-1,500
-4% -$16.4K
SBRA icon
1096
Sabra Healthcare REIT
SBRA
$5.13B
$334K 0.01%
+23,926
New +$306K
L icon
1097
Loews
L
$23.2B
$332K 0.01%
5,251
-1,000
-16% -$62.3K
SPYG icon
1098
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.9B
$331K 0.01%
5,590
-1,356
-20% -$83.1K
EXG icon
1099
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$3.08B
$328K 0.01%
44,538
-4,499
-9% -$35K
BXP icon
1100
Boston Properties
BXP
$10.9B
$328K 0.01%
+5,510
New +$353K

Similar funds

Oppenheimer & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Oppenheimer & Co held 1,493 positions worth $4.84B, down 3.1% from $5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q3 2023 filing shows 82 new, 580 increased, 615 reduced and 118 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M. The largest sale was FT Vest US Equity Deep Buffer ETF December, an estimated $15.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2023 buy was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M.
  • Oppenheimer & Co added most to ConocoPhillips in Q3 2023, an estimated $4.53M increase.
  • Oppenheimer & Co's biggest Q3 2023 reduction was Equitrans Midstream Corporation Common Stock, cutting an estimated $7.88M.
  • Oppenheimer & Co fully exited FT Vest US Equity Deep Buffer ETF December in Q3 2023, selling an estimated $15.1M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $4.84B portfolio in Q3 2023.
  • Oppenheimer & Co opened 82 new positions and closed 118 in Q3 2023.
  • Oppenheimer & Co's portfolio value fell 3.1% quarter-over-quarter to $4.84B.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.